SCA


Healthy Q3 results; more importantly, forests revalued at c.2x book value

31/10/19 -"As expected, pricing normalisation is gathering momentum across the respective divisions. Yet, SCA’s Q3 profitability exceeded consensus estimates (by an impressive margin). Moreover, the ..."

Pages
57
Language
English
Published on
31/10/19
You may also be interested by these reports :
28/03/24
Termination of coverage

19/03/24
Challenging second half

14/03/24
Weekly preview (19 March): Solid results in a challenging market

13/03/24
Despite the serious sector-wide challenges in 2023, Holmen managed to maintain healthy operating margins (>20%), which were also much-better than ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO